EVALUATION OF 4F-PCC IN OBESE VERSUS NON-OBESE PATIENTS FOR FACTOR XA INHIBITOR REVERSAL

被引：0
|
作者：
Ciborowski, Megan
Nakajima, Steven
Sparks, Eric [1 ]
McKinney, James, III [1 ]
机构：
[1] New Hanover Reg Med Ctr, Wilmington, NC USA
来源：
CRITICAL CARE MEDICINE | 2020年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1791
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparison of Anti-Xa Levels in Obese and Non-Obese Pediatric Patients Receiving Treatment Doses of Enoxaparin
    Richard, Ashley A.
    Kim, Shelly
    Moffett, Brady S.
    Bomgaars, Lisa
    Mahoney, Donald, Jr.
    Yee, Donald L.
    JOURNAL OF PEDIATRICS, 2013, 162 (02): : 293 - 296
  • [42] COST COMPARISON OF ANDEXANET VERSUS PCC FOR DIRECT FACTOR XA INHIBITOR REVERSAL AFTER HEMORRHAGE
    Frontera, Jennier
    Joset, Danielle
    Lalchan, Rebecca
    Ahuja, Tania
    Papadopoulis, John
    CRITICAL CARE MEDICINE, 2019, 47
  • [43] Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries
    Elci, Erkan
    Kaya, Cihan
    Cim, Numan
    Yildizhan, Recep
    Elci, Gulhan Gunes
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (01) : 43 - 47
  • [44] Evaluation of the impact of weight estimations on anticoagulation reversal with 4-factor prothrombin complex concentrate (4F-PCC) in the emergency department
    Vidal, Jennifer
    Procopio, Gabrielle
    Faley, Brian
    PHARMACOTHERAPY, 2016, 36 (12): : E230 - E230
  • [45] THROMBOTIC COMPLICATIONS FOLLOWING 4F-PCC FOR WARFARIN REVERSAL IN MECHANICAL HEART VALVE PATIENTS
    Lewis, Elizabeth
    Ice, Calvin
    Steensma, Elizabeth
    Saunders, Rachel
    Parker, Jessica
    CRITICAL CARE MEDICINE, 2020, 48
  • [46] Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients
    Lin, Hsin
    Yeh, Daniel Dante
    Levine, Alexander R.
    CRITICAL CARE, 2016, 20
  • [47] Colorectal cancer screening among obese versus non-obese patients in primary care practices
    Ferrante, Jeanne M.
    Ohman-Strickland, Pamela
    Hudson, Shawna V.
    Hahn, Karissa A.
    Scott, John G.
    Crabtree, Benjamin F.
    CANCER DETECTION AND PREVENTION, 2006, 30 (05): : 459 - 465
  • [48] Argatroban anticoagulation for heparin-induced thrombocytopenia in obese, versus non-obese, patients.
    Rice, Lawrence
    Hursting, Marcie J.
    McCollum, David A.
    BLOOD, 2006, 108 (11) : 431A - 431A
  • [49] Effectiveness of Valsartan in Obese Versus Non-Obese Type 2 Diabetic patients presented with microalbuminuria
    Khan, Muhammad Kashif
    Khan, Shakeel
    Khan, Ahmad Shamim
    Sultan, Khawar
    Ahmad, Armughan
    Khalid, Usman
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (10): : 2673 - 2675
  • [50] Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients
    Hsin Lin
    Daniel Dante Yeh
    Alexander R. Levine
    Critical Care, 20
12345